Published in Proc Natl Acad Sci U S A on October 15, 2003
Hydrogels as extracellular matrix mimics for 3D cell culture. Biotechnol Bioeng (2009) 4.72
Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A (2007) 3.19
Engineered microenvironments for controlled stem cell differentiation. Tissue Eng Part A (2009) 2.48
Synthetic nanostructures inducing differentiation of human mesenchymal stem cells into neuronal lineage. Exp Cell Res (2007) 2.46
Unraveling the microenvironmental influences on the normal mammary gland and breast cancer. Semin Cancer Biol (2008) 2.41
In vivo commitment and functional tissue regeneration using human embryonic stem cell-derived mesenchymal cells. Proc Natl Acad Sci U S A (2008) 1.99
Engineering hydrogels as extracellular matrix mimics. Nanomedicine (Lond) (2010) 1.86
Designing synthetic materials to control stem cell phenotype. Curr Opin Chem Biol (2007) 1.73
Bioactive hydrogel scaffolds for controllable vascular differentiation of human embryonic stem cells. Biomaterials (2007) 1.72
Controlled differentiation of stem cells. Adv Drug Deliv Rev (2007) 1.72
Endochondral bone tissue engineering using embryonic stem cells. Proc Natl Acad Sci U S A (2008) 1.70
The differentiation of embryonic stem cells seeded on electrospun nanofibers into neural lineages. Biomaterials (2008) 1.58
Scalable stirred-suspension bioreactor culture of human pluripotent stem cells. Tissue Eng Part A (2010) 1.44
Three-dimensional biomaterials for the study of human pluripotent stem cells. Nat Methods (2011) 1.42
Nanotopographical control of stem cell differentiation. J Tissue Eng (2010) 1.38
Incorporation of biomaterials in multicellular aggregates modulates pluripotent stem cell differentiation. Biomaterials (2010) 1.35
Neural differentiation of human embryonic stem cells. J Cell Biochem (2008) 1.35
Endothelial potential of human embryonic stem cells. Blood (2007) 1.34
Culture of HepG2 liver cells on three dimensional polystyrene scaffolds enhances cell structure and function during toxicological challenge. J Anat (2007) 1.31
Optimization of fibrin scaffolds for differentiation of murine embryonic stem cells into neural lineage cells. Biomaterials (2006) 1.29
Bioengineering heart muscle: a paradigm for regenerative medicine. Annu Rev Biomed Eng (2011) 1.26
Biomaterials approach to expand and direct differentiation of stem cells. Mol Ther (2007) 1.24
The effects of soluble growth factors on embryonic stem cell differentiation inside of fibrin scaffolds. Stem Cells (2007) 1.23
Recellularization of well-preserved acellular kidney scaffold using embryonic stem cells. Tissue Eng Part A (2014) 1.18
Stem cell bioprocessing: fundamentals and principles. J R Soc Interface (2009) 1.17
Development of biomaterial scaffold for nerve tissue engineering: Biomaterial mediated neural regeneration. J Biomed Sci (2009) 1.16
Microencapsulation technology: a powerful tool for integrating expansion and cryopreservation of human embryonic stem cells. PLoS One (2011) 1.13
The influence of scaffold elasticity on germ layer specification of human embryonic stem cells. Biomaterials (2011) 1.13
NF-κB gene signature predicts prostate cancer progression. Cancer Res (2014) 1.09
The enhancement of human embryonic stem cell osteogenic differentiation with nano-fibrous scaffolding. Biomaterials (2010) 1.07
The effect of controlled growth factor delivery on embryonic stem cell differentiation inside fibrin scaffolds. Stem Cell Res (2008) 1.06
Mesenchymal stem cells for vascular regeneration. Regen Med (2008) 1.06
Neural conversion of ES cells by an inductive activity on human amniotic membrane matrix. Proc Natl Acad Sci U S A (2006) 1.05
Three-dimensional epithelial tissues generated from human embryonic stem cells. Tissue Eng Part A (2009) 1.04
Chronic label-free volumetric photoacoustic microscopy of melanoma cells in three-dimensional porous scaffolds. Biomaterials (2010) 1.03
Isolation, differentiation and characterization of vascular cells derived from human embryonic stem cells. Nat Protoc (2010) 1.02
Radioresistance of glioma stem cells: intrinsic characteristic or property of the 'microenvironment-stem cell unit'? Mol Oncol (2011) 1.01
Mechanical characterization of differentiated human embryonic stem cells. J Biomech Eng (2009) 1.01
Asymmetric distribution of UCH-L1 in spermatogonia is associated with maintenance and differentiation of spermatogonial stem cells. J Cell Physiol (2009) 1.01
Cell therapy for spinal cord regeneration. Adv Drug Deliv Rev (2007) 0.99
Decellularized tissue and cell-derived extracellular matrices as scaffolds for orthopaedic tissue engineering. Biotechnol Adv (2014) 0.99
Engineering tissue from human embryonic stem cells. J Cell Mol Med (2008) 0.98
Fibrochondrogenesis of hESCs: growth factor combinations and cocultures. Stem Cells Dev (2009) 0.98
Strategies for organ level tissue engineering. Organogenesis (2011) 0.98
Human embryonic stem cell encapsulation in alginate microbeads in macroporous calcium phosphate cement for bone tissue engineering. Acta Biomater (2012) 0.98
nAChRs mediate human embryonic stem cell-derived endothelial cells: proliferation, apoptosis, and angiogenesis. PLoS One (2009) 0.97
Peptide hydrogelation and cell encapsulation for 3D culture of MCF-7 breast cancer cells. PLoS One (2013) 0.95
Drug releasing systems in cardiovascular tissue engineering. J Cell Mol Med (2009) 0.95
Hepatocyte progenitors in man and in rodents--multiple pathways, multiple candidates. Int J Exp Pathol (2005) 0.95
Designer blood: creating hematopoietic lineages from embryonic stem cells. Blood (2005) 0.93
Using physiologically-based pharmacokinetic-guided "body-on-a-chip" systems to predict mammalian response to drug and chemical exposure. Exp Biol Med (Maywood) (2014) 0.93
Engineered vascular beds provide key signals to pancreatic hormone-producing cells. PLoS One (2012) 0.93
Microvascular repair: post-angiogenesis vascular dynamics. Microcirculation (2012) 0.92
3D culture of adult mouse neural stem cells within functionalized self-assembling peptide scaffolds. Int J Nanomedicine (2011) 0.92
Substratum topography modulates corneal fibroblast to myofibroblast transformation. Invest Ophthalmol Vis Sci (2012) 0.91
Regulation of the matrix microenvironment for stem cell engineering and regenerative medicine. Ann Biomed Eng (2011) 0.90
Real-time in vivo monitoring of viable stem cells implanted on biocompatible scaffolds. Eur J Nucl Med Mol Imaging (2008) 0.90
Nanoscale tissue engineering: spatial control over cell-materials interactions. Nanotechnology (2011) 0.90
Microscale technologies and modular approaches for tissue engineering: moving toward the fabrication of complex functional structures. ACS Nano (2011) 0.89
Induction of fracture repair by mesenchymal cells derived from human embryonic stem cells or bone marrow. J Orthop Res (2011) 0.89
Bioartificial Renal Epithelial Cell System (BRECS): A Compact, Cryopreservable Extracorporeal Renal Replacement Device. Cell Med (2012) 0.88
Carbon nanotube interaction with extracellular matrix proteins producing scaffolds for tissue engineering. Int J Nanomedicine (2012) 0.88
Embryoid body formation from embryonic and induced pluripotent stem cells: Benefits of bioreactors. World J Stem Cells (2009) 0.88
Three-dimensional scaffolding to investigate neuronal derivatives of human embryonic stem cells. Biomed Microdevices (2012) 0.87
One-Step Multipurpose Surface Functionalization by Adhesive Catecholamine. Adv Funct Mater (2012) 0.87
Engaging stem cells for customized tendon regeneration. Stem Cells Int (2012) 0.86
Engineering retina from human retinal progenitors (cell lines). Tissue Eng Part A (2009) 0.85
The maintenance of pluripotency following laser direct-write of mouse embryonic stem cells. Biomaterials (2010) 0.85
Biomaterials directed in vivo osteogenic differentiation of mesenchymal cells derived from human embryonic stem cells. Tissue Eng Part A (2013) 0.85
Sustained embryoid body formation and culture in a non-laborious three dimensional culture system for human embryonic stem cells. Cytotechnology (2011) 0.85
Advances in 3D cell culture technologies enabling tissue-like structures to be created in vitro. J Anat (2014) 0.84
On human pluripotent stem cell control: The rise of 3D bioengineering and mechanobiology. Biomaterials (2015) 0.84
Differential expression of neuronal genes in Müller glia in two- and three-dimensional cultures. Invest Ophthalmol Vis Sci (2011) 0.84
Extracellular matrix aggregates from differentiating embryoid bodies as a scaffold to support ESC proliferation and differentiation. PLoS One (2013) 0.84
Human adipose stem cells maintain proliferative, synthetic and multipotential properties when suspension cultured as self-assembling spheroids. Biofabrication (2012) 0.84
Fabrication and selective functionalization of amine-reactive polymer multilayers on topographically patterned microwell cell culture arrays. Biomacromolecules (2011) 0.84
Engineering approaches toward deconstructing and controlling the stem cell environment. Ann Biomed Eng (2011) 0.83
Role of bioinspired polymers in determination of pluripotent stem cell fate. Regen Med (2009) 0.83
Challenges and strategies for generating therapeutic patient-specific hemangioblasts and hematopoietic stem cells from human pluripotent stem cells. Int J Dev Biol (2010) 0.83
Harnessing biomechanics to develop cartilage regeneration strategies. J Biomech Eng (2015) 0.83
Synthetic Extracellular Microenvironment for Modulating Stem Cell Behaviors. Biomark Insights (2015) 0.82
Generating cartilage repair from pluripotent stem cells. Tissue Eng Part B Rev (2013) 0.81
Nanofibrous substrates support colony formation and maintain stemness of human embryonic stem cells. J Cell Mol Med (2009) 0.81
In vitro and in vivo evaluation of zinc-modified ca-si-based ceramic coating for bone implants. PLoS One (2013) 0.81
Layer-by-layer paper-stacking nanofibrous membranes to deliver adipose-derived stem cells for bone regeneration. Int J Nanomedicine (2015) 0.80
Biophysical and chemical effects of fibrin on mesenchymal stromal cell gene expression. Acta Biomater (2010) 0.80
Fucoidan promotes early step of cardiac differentiation from human embryonic stem cells and long-term maintenance of beating areas. Tissue Eng Part A (2014) 0.80
Material Cues as Potent Regulators of Epigenetics and Stem Cell Function. Cell Stem Cell (2016) 0.80
Engineering of the embryonic and adult stem cell niches. Iran Red Crescent Med J (2013) 0.79
Smooth muscle and other cell sources for human blood vessel engineering. Cells Tissues Organs (2011) 0.79
Generation of a human embryonic stem cell line stably expressing high levels of the fluorescent protein mCherry. World J Stem Cells (2012) 0.79
Oriented, multimeric biointerfaces of the L1 cell adhesion molecule: an approach to enhance neuronal and neural stem cell functions on 2-D and 3-D polymer substrates. Biointerphases (2012) 0.79
Induced Pluripotent Stem Cells-A New Foundation in Medicine. J Exp Clin Med (2010) 0.79
Region-specific differentiation potential of adult rat spinal cord neural stem/precursors and their plasticity in response to in vitro manipulation. J Histochem Cytochem (2009) 0.78
Polymeric Nanomedicines Based on Poly(lactide) and Poly(lactide-co-glycolide). Curr Opin Solid State Mater Sci (2012) 0.78
Carriers in cell-based therapies for neurological disorders. Int J Mol Sci (2014) 0.77
Embryonic and induced pluripotent stem cells as a model for liver disease. Crit Rev Biomed Eng (2009) 0.77
Bridging the Gap: From 2D Cell Culture to 3D Microengineered Extracellular Matrices. Adv Healthc Mater (2015) 0.76
Tensile forces applied on a cell-embedded three-dimensional scaffold can direct early differentiation of embryonic stem cells toward the mesoderm germ layer. Tissue Eng Part A (2014) 0.76
Embryonic stem cell lines derived from human blastocysts. Science (1998) 65.53
Polymeric system for dual growth factor delivery. Nat Biotechnol (2001) 7.20
Differentiation of human embryonic stem cells into embryoid bodies compromising the three embryonic germ layers. Mol Med (2000) 5.83
Neural progenitors from human embryonic stem cells. Nat Biotechnol (2001) 4.48
Hematopoietic colony-forming cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2001) 4.07
Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 3.66
Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2000) 3.62
Multilineage differentiation from human embryonic stem cell lines. Stem Cells (2001) 3.22
Enrichment of neurons and neural precursors from human embryonic stem cells. Exp Neurol (2001) 2.63
Tissue engineering: the design and fabrication of living replacement devices for surgical reconstruction and transplantation. Lancet (1999) 2.62
Induced neuronal differentiation of human embryonic stem cells. Brain Res (2001) 2.12
Human embryonic germ cell derivatives express a broad range of developmentally distinct markers and proliferate extensively in vitro. Proc Natl Acad Sci U S A (2001) 1.67
The end of the beginning for pluripotent stem cells. Nature (2001) 1.65
Immunochemical and mechanical characterization of cartilage subtypes in rabbit. J Histochem Cytochem (2002) 1.56
Endoderm-specific gene expression in embryonic stem cells differentiated to embryoid bodies. Exp Cell Res (1996) 1.52
Embryonic stem cell-derived neurogenesis. Retinoic acid induction and lineage selection of neuronal cells. Cell Tissue Res (2001) 1.50
Principals of neovascularization for tissue engineering. Mol Aspects Med (2002) 1.44
Potential of embryonic stem cells. Mol Aspects Med (2001) 1.35
Embryogenesis in vitro: study of differentiation of embryonic stem cells. Biol Neonate (1995) 0.96
Nanocarriers as an emerging platform for cancer therapy. Nat Nanotechnol (2007) 17.80
Knocking down barriers: advances in siRNA delivery. Nat Rev Drug Discov (2009) 12.46
Characterization of human embryonic stem cell lines by the International Stem Cell Initiative. Nat Biotechnol (2007) 9.36
Heat shock factor 1 is a powerful multifaceted modifier of carcinogenesis. Cell (2007) 8.84
Engineering vascularized skeletal muscle tissue. Nat Biotechnol (2005) 7.73
Intestinal inflammation targets cancer-inducing activity of the microbiota. Science (2012) 7.54
Targeted nanoparticle-aptamer bioconjugates for cancer chemotherapy in vivo. Proc Natl Acad Sci U S A (2006) 6.90
Impact of nanotechnology on drug delivery. ACS Nano (2009) 6.87
A combinatorial library of lipid-like materials for delivery of RNAi therapeutics. Nat Biotechnol (2008) 6.81
Microscale technologies for tissue engineering and biology. Proc Natl Acad Sci U S A (2006) 6.66
Gastric cancer originating from bone marrow-derived cells. Science (2004) 6.04
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile. Sci Transl Med (2012) 5.92
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol (2004) 5.51
Transdermal drug delivery. Nat Biotechnol (2008) 5.11
Adipose tissue mass can be regulated through the vasculature. Proc Natl Acad Sci U S A (2002) 4.77
Therapeutic RNAi targeting PCSK9 acutely lowers plasma cholesterol in rodents and LDL cholesterol in nonhuman primates. Proc Natl Acad Sci U S A (2008) 4.57
Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells. Cancer Res (2004) 4.56
Combined postmenopausal hormone therapy and cardiovascular disease: toward resolving the discrepancy between observational studies and the Women's Health Initiative clinical trial. Am J Epidemiol (2005) 4.55
Electromechanical integration of cardiomyocytes derived from human embryonic stem cells. Nat Biotechnol (2004) 4.50
Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol (2008) 4.46
The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J Exp Med (2010) 4.37
A tough biodegradable elastomer. Nat Biotechnol (2002) 4.35
Lipid-like materials for low-dose, in vivo gene silencing. Proc Natl Acad Sci U S A (2010) 4.25
Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds. Proc Natl Acad Sci U S A (2004) 4.13
Formulation of functionalized PLGA-PEG nanoparticles for in vivo targeted drug delivery. Biomaterials (2006) 4.09
Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med (2005) 4.04
Accordion-like honeycombs for tissue engineering of cardiac anisotropy. Nat Mater (2008) 4.00
A reversibly switching surface. Science (2003) 3.97
Therapeutic siRNA silencing in inflammatory monocytes in mice. Nat Biotechnol (2011) 3.95
Small-scale systems for in vivo drug delivery. Nat Biotechnol (2003) 3.90
Precise engineering of targeted nanoparticles by using self-assembled biointegrated block copolymers. Proc Natl Acad Sci U S A (2008) 3.80
Nanoparticle delivery of cancer drugs. Annu Rev Med (2011) 3.75
Gene expression in human embryonic stem cell lines: unique molecular signature. Blood (2003) 3.73
Endothelial cells derived from human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 3.66
Targeted delivery of cisplatin to prostate cancer cells by aptamer functionalized Pt(IV) prodrug-PLGA-PEG nanoparticles. Proc Natl Acad Sci U S A (2008) 3.62
First-in-human testing of a wirelessly controlled drug delivery microchip. Sci Transl Med (2012) 3.56
Activation of beta-catenin by carcinogenic Helicobacter pylori. Proc Natl Acad Sci U S A (2005) 3.52
Controlled degradation and mechanical behavior of photopolymerized hyaluronic acid networks. Biomacromolecules (2005) 3.44
Current status and future potential of transdermal drug delivery. Nat Rev Drug Discov (2004) 3.41
Oncomodulin is a macrophage-derived signal for axon regeneration in retinal ganglion cells. Nat Neurosci (2006) 3.35
Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc Natl Acad Sci U S A (2002) 3.35
Treating metastatic cancer with nanotechnology. Nat Rev Cancer (2011) 3.30
Differences between human and mouse embryonic stem cells. Dev Biol (2004) 3.30
High-resolution DNA analysis of human embryonic stem cell lines reveals culture-induced copy number changes and loss of heterozygosity. Nat Biotechnol (2010) 3.21
Hyaluronic acid hydrogel for controlled self-renewal and differentiation of human embryonic stem cells. Proc Natl Acad Sci U S A (2007) 3.19
DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest (2008) 3.17
Outbreak of adverse reactions associated with contaminated heparin. N Engl J Med (2008) 3.16
Nanotechnological strategies for engineering complex tissues. Nat Nanotechnol (2010) 3.15
Combinatorial development of biomaterials for clonal growth of human pluripotent stem cells. Nat Mater (2010) 3.11
Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol (2012) 3.09
Engineering substrate topography at the micro- and nanoscale to control cell function. Angew Chem Int Ed Engl (2009) 3.09
Microengineered hydrogels for tissue engineering. Biomaterials (2007) 2.87
Semi-automated synthesis and screening of a large library of degradable cationic polymers for gene delivery. Angew Chem Int Ed Engl (2003) 2.83
The inflammatory responses to silk films in vitro and in vivo. Biomaterials (2005) 2.79
Biodegradable, elastic shape-memory polymers for potential biomedical applications. Science (2002) 2.79
High-efficiency RNA interference in human embryonic stem cells. Stem Cells (2005) 2.76
Self-assembled lipid--polymer hybrid nanoparticles: a robust drug delivery platform. ACS Nano (2008) 2.76
CD4+ CD25+ regulatory T lymphocytes inhibit microbially induced colon cancer in Rag2-deficient mice. Am J Pathol (2003) 2.70
Nanomedicine: developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev (2006) 2.69
No significant endothelial apoptosis in the radiation-induced gastrointestinal syndrome. Int J Radiat Oncol Biol Phys (2007) 2.68
Multi-pulse drug delivery from a resorbable polymeric microchip device. Nat Mater (2003) 2.65
A combinatorial polymer library approach yields insight into nonviral gene delivery. Acc Chem Res (2008) 2.63
A biodegradable and biocompatible gecko-inspired tissue adhesive. Proc Natl Acad Sci U S A (2008) 2.58
Macroporous nanowire nanoelectronic scaffolds for synthetic tissues. Nat Mater (2012) 2.57
Characterization of the expression of MHC proteins in human embryonic stem cells. Proc Natl Acad Sci U S A (2002) 2.53
Light-induced shape-memory polymers. Nature (2005) 2.52
Risk of cardiovascular disease by hysterectomy status, with and without oophorectomy: the Women's Health Initiative Observational Study. Circulation (2005) 2.49
Medium perfusion enables engineering of compact and contractile cardiac tissue. Am J Physiol Heart Circ Physiol (2003) 2.42
Quantum dot-aptamer conjugates for synchronous cancer imaging, therapy, and sensing of drug delivery based on bi-fluorescence resonance energy transfer. Nano Lett (2007) 2.40
A vector-free microfluidic platform for intracellular delivery. Proc Natl Acad Sci U S A (2013) 2.40
Development of lipidoid-siRNA formulations for systemic delivery to the liver. Mol Ther (2009) 2.39
An aptamer-doxorubicin physical conjugate as a novel targeted drug-delivery platform. Angew Chem Int Ed Engl (2006) 2.38
Bio-inspired polymer composite actuator and generator driven by water gradients. Science (2013) 2.38
LIF/STAT3 signaling fails to maintain self-renewal of human embryonic stem cells. Stem Cells (2004) 2.37
Nanotechnology in drug delivery and tissue engineering: from discovery to applications. Nano Lett (2010) 2.35
Controlling size, shape and homogeneity of embryoid bodies using poly(ethylene glycol) microwells. Lab Chip (2007) 2.30
Biocompatibility and biofouling of MEMS drug delivery devices. Biomaterials (2003) 2.27
Bone tissue engineering using human mesenchymal stem cells: effects of scaffold material and medium flow. Ann Biomed Eng (2004) 2.26
Endothelialized microvasculature based on a biodegradable elastomer. Tissue Eng (2005) 2.23
Silk implants for the healing of critical size bone defects. Bone (2005) 2.22
PLGA-lecithin-PEG core-shell nanoparticles for controlled drug delivery. Biomaterials (2008) 2.21
Engineering of self-assembled nanoparticle platform for precisely controlled combination drug therapy. Proc Natl Acad Sci U S A (2010) 2.21
Biomimetic approach to cardiac tissue engineering: oxygen carriers and channeled scaffolds. Tissue Eng (2006) 2.20
Expression of p16(INK4a) prevents cancer and promotes aging in lymphocytes. Blood (2011) 2.16
Multipotent vasculogenic pericytes from human pluripotent stem cells promote recovery of murine ischemic limb. Circulation (2011) 2.16
Identification of cholelithogenic enterohepatic helicobacter species and their role in murine cholesterol gallstone formation. Gastroenterology (2005) 2.15
Micromolding of shape-controlled, harvestable cell-laden hydrogels. Biomaterials (2006) 2.12
Nanostructured materials for applications in drug delivery and tissue engineering. J Biomater Sci Polym Ed (2007) 2.12
Vascular progenitor cells isolated from human embryonic stem cells give rise to endothelial and smooth muscle like cells and form vascular networks in vivo. Circ Res (2007) 2.12
Progress in tissue engineering. Sci Am (2009) 2.08
NLRP12 suppresses colon inflammation and tumorigenesis through the negative regulation of noncanonical NF-κB signaling. Immunity (2012) 2.07
Functional properties of human embryonic stem cell-derived cardiomyocytes: intracellular Ca2+ handling and the role of sarcoplasmic reticulum in the contraction. Stem Cells (2005) 2.06
Assessment of the ultrastructural and proliferative properties of human embryonic stem cell-derived cardiomyocytes. Am J Physiol Heart Circ Physiol (2003) 2.05
In vivo engineering of organs: the bone bioreactor. Proc Natl Acad Sci U S A (2005) 2.04
Molecularly engineered poly(ortho ester) microspheres for enhanced delivery of DNA vaccines. Nat Mater (2004) 2.03
Poly-beta amino ester-containing microparticles enhance the activity of nonviral genetic vaccines. Proc Natl Acad Sci U S A (2004) 2.03
Human embryonic and induced pluripotent stem cell-derived cardiomyocytes exhibit beat rate variability and power-law behavior. Circulation (2012) 2.02
Oxygen gradients correlate with cell density and cell viability in engineered cardiac tissue. Biotechnol Bioeng (2006) 2.01
In vivo degradation characteristics of poly(glycerol sebacate). J Biomed Mater Res A (2003) 2.01